Cargando…
The COVID-19 Pandemic – A Diagnostic Industry Perspective
The COVID-19 pandemic has brought about unprecedented changes to all facets of the healthcare system, including the diagnostic industry. The pandemic has highlighted both the challenges and strengths of the industry and has also provided valuable insights on how to be better prepared for future pand...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988131/ https://www.ncbi.nlm.nih.gov/pubmed/35402288 http://dx.doi.org/10.3389/fcimb.2022.862440 |
_version_ | 1784682894844755968 |
---|---|
author | Das, Shubhagata Dunbar, Sherry |
author_facet | Das, Shubhagata Dunbar, Sherry |
author_sort | Das, Shubhagata |
collection | PubMed |
description | The COVID-19 pandemic has brought about unprecedented changes to all facets of the healthcare system, including the diagnostic industry. The pandemic has highlighted both the challenges and strengths of the industry and has also provided valuable insights on how to be better prepared for future pandemics. In this perspective article, we describe the challenges faced by the diagnostic industry in general, particularly the difficulties encountered by Luminex Corporation, a diagnostic assay development and manufacturing company located in Austin, Texas, USA, as well as the mitigation strategies employed. In addition to discussion of the key challenges, the article provides insights on the lessons learned and steps that can be undertaken to better prepare for future outbreaks. |
format | Online Article Text |
id | pubmed-8988131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89881312022-04-08 The COVID-19 Pandemic – A Diagnostic Industry Perspective Das, Shubhagata Dunbar, Sherry Front Cell Infect Microbiol Cellular and Infection Microbiology The COVID-19 pandemic has brought about unprecedented changes to all facets of the healthcare system, including the diagnostic industry. The pandemic has highlighted both the challenges and strengths of the industry and has also provided valuable insights on how to be better prepared for future pandemics. In this perspective article, we describe the challenges faced by the diagnostic industry in general, particularly the difficulties encountered by Luminex Corporation, a diagnostic assay development and manufacturing company located in Austin, Texas, USA, as well as the mitigation strategies employed. In addition to discussion of the key challenges, the article provides insights on the lessons learned and steps that can be undertaken to better prepare for future outbreaks. Frontiers Media S.A. 2022-03-24 /pmc/articles/PMC8988131/ /pubmed/35402288 http://dx.doi.org/10.3389/fcimb.2022.862440 Text en Copyright © 2022 Das and Dunbar https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Das, Shubhagata Dunbar, Sherry The COVID-19 Pandemic – A Diagnostic Industry Perspective |
title | The COVID-19 Pandemic – A Diagnostic Industry Perspective |
title_full | The COVID-19 Pandemic – A Diagnostic Industry Perspective |
title_fullStr | The COVID-19 Pandemic – A Diagnostic Industry Perspective |
title_full_unstemmed | The COVID-19 Pandemic – A Diagnostic Industry Perspective |
title_short | The COVID-19 Pandemic – A Diagnostic Industry Perspective |
title_sort | covid-19 pandemic – a diagnostic industry perspective |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988131/ https://www.ncbi.nlm.nih.gov/pubmed/35402288 http://dx.doi.org/10.3389/fcimb.2022.862440 |
work_keys_str_mv | AT dasshubhagata thecovid19pandemicadiagnosticindustryperspective AT dunbarsherry thecovid19pandemicadiagnosticindustryperspective AT dasshubhagata covid19pandemicadiagnosticindustryperspective AT dunbarsherry covid19pandemicadiagnosticindustryperspective |